Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 13,770,000 shares, a decrease of 29.0% from the September 30th total of 19,400,000 shares. Currently, 16.3% of the company’s shares are short sold. […]
Capital Impact Advisors LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,612 shares of the company’s stock after purchasing an additional 6,184 shares during the […]
Leerink Partnrs reaffirmed their outperform rating on shares of Relay Therapeutics (NASDAQ:RLAY – Free Report) in a report released on Tuesday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Relay Therapeutics’ Q2 2023 earnings at ($0.87) EPS, Q3 2023 earnings at ($0.90) EPS, Q4 2023 earnings at ($0.93) EPS, FY2023 earnings at ($3.48) EPS, FY2024 […]
Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results, Misses Expectations By $0 03 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Investment analysts at SVB Securities began coverage on shares of Relay Therapeutics (NASDAQ:RLAY – Get Free Report) in a research note issued on Tuesday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the stock. Other equities analysts have also recently issued research reports about the stock. Raymond James upgraded shares of Relay Therapeutics from […]